Stay updated on Cabiralizumab Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays Revision: v3.6.3 in place of Revision: v3.6.2, updating the site's version label. This documents a minor version update to the system label used on the page.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision: v3.6.2 is now displayed on the page, signaling a minor platform update. This change does not modify study content or how the page appears to users.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now indicates recruitment is closed and introduces new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), plus a revision notice.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, indicating a small maintenance update to the study record page.SummaryDifference0.0%

- Check70 days agoChange DetectedA new revision tag, Revision: v3.5.4, was added and the previous Revision: v3.5.3 was removed, indicating a version update for the study record.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page’s footer software revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Cabiralizumab Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.